HESI RN · Integumentary system drugs
Question 1 of 3
Select an option. Use Strike to cross one out.
Rationale
Did you know the question?
HESI RN · Integumentary system drugs
Question 1 of 3
Select an option. Use Strike to cross one out.
Rationale
Did you know the question?
HESI RN · Integumentary system drugs
Question 2 of 3
Select an option. Use Strike to cross one out.
Rationale
Did you know the question?
HESI RN · Integumentary system drugs
Question 3 of 3
Select an option. Use Strike to cross one out.
Rationale
Option A: Topical betamethasone is a potent corticosteroid that effectively reduces inflammation and itching associated with eczema, making it a first-line treatment in managing this condition. Its anti-inflammatory properties help to alleviate symptoms and promote skin healing.
Option B: Topical alpha-tocopherol, while an antioxidant, does not have established efficacy in treating eczema and lacks the anti-inflammatory action needed for effective management.
Option C: Dithranol is primarily used for psoriasis and is not indicated for eczema, as it can cause irritation and is not effective for this condition.
Option D: Calcipotriol is a vitamin D analog used mainly for psoriasis treatment and does not address the inflammatory component of eczema effectively.
Takeaways: Effective management of eczema often involves the use of topical corticosteroids like betamethasone, which significantly reduce inflammation and itching, requiring appropriate patient education on its use to ensure safe and effective treatment.
Did you know the question?
You have finished the first five questions. Sign in to continue this set and save your progress.